Concepedia

Kyle N. Goodman

KN

Statistics

Publications

4

Citations

127

H-Index

4

Active since

2014

Affiliations

National Institutes of Health(Current)

National Institute of Allergy and Infectious Diseases

National Cancer Institute

Kyle N. Goodman is an author at National Institutes of Health specializing in herpes simplex virus vaccines, life sciences, and infectious diseases.

Publications per year

2014–2020

4

Publications

4

Topical Herpes Simplex Virus 2 (HSV-2) Vaccination with Human Papillomavirus Vectors Expressing gB/gD Ectodomains Induces Genital-Tissue-Resident Memory CD8<sup>+</sup>T Cells and Reduces Genital Disease and Viral Shedding after HSV-2 Challenge

Nicolas Çuburu, Kening Wang, Kyle N. Goodman et al. · Journal of Virology · 2014 · 42 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

A Herpes Simplex Virus 2 (HSV-2) gD Mutant Impaired for Neural Tropism Is Superior to an HSV-2 gD Subunit Vaccine To Protect Animals from Challenge with HSV-2

Kening Wang, Kyle N. Goodman, Daniel Y. Li et al. · Journal of Virology · 2015 · 29 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1

Kening Wang, Georgia D. Tomaras, Sinthujan Jegaskanda et al. · Journal of Virology · 2017 · 28 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

<i>Campylobacter jejuni</i> BumSR directs a response to butyrate via sensor phosphatase activity to impact transcription and colonization

Kyle N. Goodman, Matthew J. Powers, Alexander A. Crofts et al. · Proceedings of the National Academy of Sciences · 2020 · 28 citations · Full text

Life Sciences, Microbiology, Molecular Biology +17

1–4 of 4